Member Info for Thompi

Just registered for the AGL presentation with Proactive, 20th May 6.00pm.
Should be interesting.

Sound advice BOJO, enthusiasm does sometimes need tempering, especially as I am a relatively new investor in AGL and have bought and topped up close to 52 week highs.
I understand the risk if there are delays to FDA approval etc. But the “head” still says go for it, the prospects in the mid-long term are huge. GLA

Thanks Yuyus for the link. The more I read, and the more interviews and presentations I watch the more impressed I am with this company. It’s potential is awesome.
The article is very interesting. I didn’t realise, for example, that in addition to all the other benefits “live CTCs harvested by Parsortix can be cultured, allowing the potential for testing tumour response to drugs outside of the patient’s body.”
Seriously impressed.

Agreed Moniman, I don’t think CF suffers fools gladly. If it’s not the P45, then a considerable hoof up the a**e.

Hi DumbledoresBeard,

I’m guessing they do check the board. I emailed the following yesterday and got a similar response to Demon & Wondergoals. Top marks to ORPH and their attention to their investors, I am impressed.

“Hi Open Orphan,

Please will you have a read of the Open Orphan LSE chat board to gauge your investor’s feelings. ORPH, as you, know is well supported by its loyal long term holders, of which I include myself.

You will note a bit of disquiet regarding your broker, finnCap, leaving their forecast of 28p unchanged, albeit with “substantial room for upside”. There seems a large disconnect between the current SP and their forecast which has been perceived as having a detrimental effect on the SP performance. I appreciate, of course, that there are a lot of other factors to take into consideration.

I would be grateful if you would have a review of the finnCapp report.”

Thanks ConMan for the link, very interesting. And with you all the way Dulyred very exciting times ahead.

Regretting the timing of my top up this morning. It’s well in the red. Hope we get a bounce later in the week. It seems well oversold.

Bought a modest top up today at 35.35p.

Don’t like seeing the SP go down so much but as a LTH, confident in our prospects, hopefully it is a “drop-ortunity”

More good news.

I am a fairly new investor to Angle and very much like the company and it’s prospects. I topped up on the strength of AN’s recent presentation and their preliminary results.

As an ex-investor in Woodfords’s Patient Capital Trust the headline about Inivata being acquired by NeoGenomics caught my attention.

Looking at Inivata’s website -
“INIVATA IS A LEADER IN LIQUID BIOPSY
Unlocking essential genomic information from a simple
blood draw to transform the care of cancer patients”

Apologies if this is a stupid question, but doe anyone know if Inivata are a direct competitor to Angle?

Thanks Italian & ConMan94. If I have appeared a bit indecisive over the last few days it has been due to a few nerves adding at the top of the range. But to quote Andinio “POLX is a potential portfolio game changer.”

Hi Acty, yes I couldn’t buy with HL. I had reservations about buying at the top but I ended up biting the bullet and buying some through a broker in the end at 90p.
There well may be some profit taking and a bit of a drift, but I think in the long term I will have made the right decision. Hope so.

I’m just getting NT to buy on HL. The strength of the SP is fantastic. I don’t think I would have had bought anyhow at a 52 week high. Which is a bit paradoxical because I’m sure the SP will ultimately be a lot higher than now...
If there is any pull back then I’m in with a top up. GLA

Hi Italian, I also listened to JW’s coverage. I share some of his enthusiasm, but as you say with a degree of circumspection.
I want to top up but am in two minds whether to add now at the high end of the SP, or see if there is a bit of a retracement. I am in a similar position with Angle, which is another stock I really like. I may end up adding small amounts regularly to try and hedge my bets.
I moved a small pension into a SIPP and the intention is to go very overweight on POLX. GLA

If you can stand listening to JW there is another mention on his podcast, about 22:20 minutes in. He talks about adding to his holding (an “upper-tunity”) and that he views POLX as a potential 100 bagger and a FTSE100 company in the making.
I find JW a bit hard going, but interesting nonetheless.
Always an element or risk. The FDA might want more info etc, and I wouldn’t bet the house, but I am very excited for the future.

Morning Wacca, I am in the same boat as you. I also feel as I am too underwater to “sell up and move on”. Annoyed with myself for ignoring all the classics warning signs of BOD musical chairs etc.
Hopefully Anne will be able to turn things around but I am resigned to the fact that it is going to take a long time. Good luck and hope you didn’t buy the bulk of your shares at 7.5p like I did.

Wacca, agree with your frustrations with NFX. But Soup is the best poster on this site, very well researched and a balanced view.

It’s just a shame the churn never achieved anything meaningful with the SP.

Stick or twist, that is the question for me. I have totted up my losses and am over well over 15k down. Sometimes I am tempted to follow Whimax’s advice, and as a pretty p****d off LTH sell and move on. Still fomo, stubbornness and a hope that NFX genuinely have something to offer keeps me hanging in. For now anyhow.

I am fortunate to have had gains elsewhere. Whimax if you are tuning in, I saw your name on the ORPH board and they have a great CEO. I wish you luck with NFX and any other investments you have.

GLA

Well done Researcher1 for your buy this morning and anyone else who bought. It must be very satisfying. I was walking the dog and missed the moment, the SP was on the turn when I got back home.
To be honest, when I saw the price was 6% down I thought I must have missed something negative in the results and I probably would have bottled it. Lesson learnt.